Most Recent
Merck Sharp & Dohme loses key battle in trade mark case ahead of trial
Intellectual Property 2019-07-15 8:51 pm By Miklos Bolza

A court has barred US drug company Merck Sharp & Dohme from denying that an agreement made with German pharmaceutical company Merck KGaA was governed […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Grand Theft Auto modder confident of defence in Take-Two copyright case
Intellectual Property 2019-06-21 1:11 pm By Miklos Bolza

A developer of what’s now being called the “Infamous Mod” for video game Grand Theft Auto, which gives players extra powers, is confident he can […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Piper Alderman partner rejected offer to leave on a ‘dignified basis’, court told
Business of Law 2019-06-03 9:22 pm By Amelia Birnie

A senior Piper Alderman partner who has launched a sex discrimination case against the law firm rejected “reasonable settlement offers” that would have allowed her […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ASIC wins case against Vocation, former execs after 15-month wait for judgment
Securities 2019-05-31 6:21 pm By Miklos Bolza

In a win for the corporate watchdog, a court has found collapsed education provider Vocation engaged in misleading and deceptive conduct and breached its continuous […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Insufficient evidence Piper Alderman discriminated against female partner, judge says
Employment 2019-05-27 10:28 pm By Miklos Bolza

A judge has found a senior female partner at Piper Alderman has not provided sufficient evidence that the firm moved to oust her from its […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Piper Alderman free to oust senior female partner amid sex discrimination case
Business of Law 2019-05-24 4:22 pm By Amelia Birnie

The job of a senior Piper Alderman partner is in jeopardy after a court refused to extend an injunction preventing her from being ousted from […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Judge shoots down Mylan bid for generic Lipidil injunction
Intellectual Property 2019-04-12 4:49 pm By Cat Fredenburgh

A judge has denied Mylan’s bid to temporarily block Sun Pharma and Cipla from making generic versions of anti-cholesterol drug Lipidil while it appeals a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Lundbeck sues IP Australia, Sandoz to escape undertaking over Lexapro licence
Intellectual Property 2019-04-09 4:44 pm By Miklos Bolza

Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Generics attack validity of Neurim insomnia drug patent
Intellectual Property 2019-04-05 8:28 pm By Miklos Bolza

Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Mylan must hand over authorised generic docs ahead of injunction hearing
Intellectual Property 2019-03-25 8:29 pm By Miklos Bolza

Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.